Robert Connolly

CEO

Equibles does not estimate personal net worth.

Get an email with a short summary when Elicio Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ELTX alerts

About Robert Connolly

Robert Connolly is recorded as CEO at Elicio Therapeutics, Inc. (ELTX). Robert Connolly has spoken on 1 investor event across 1 company, most recently for Elicio Therapeutics, Inc. on June 15, 2026. Elicio Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Elicio Therapeutics, Inc. includes Robert Connelly (CEO, Chief Accounting Officer and Board Member), Julian Adams (Chairman), Julian Adams, Ph.D. (Chairman and Board Member) and 7 others.

Robert Connolly on recent calls

“While we are disappointed that the Amplify 7P study did not meet its primary endpoint, we believe the data set generated important clinical and biological insights that have informed clear development strategy moving forward.”

CEO, June 15th Conference Call · June 15, 2026

Affiliation history

Elicio Therapeutics, Inc. (ELTX)
CEO

Transcript header (unverified)

Current

Company network

Elicio Therapeutics, Inc.

ELTX

Current role

Biotechnology · Healthcare

CEO

1 appearance Latest appearance 2026-06-15

View calls and events

Leadership on record at Elicio Therapeutics, Inc.

Robert Connelly CEO, Chief Accounting Officer, Board Member
Julian Adams Chairman
Julian Adams, Ph.D. Chairman, Board Member
Brian Piekos CFO
Preetam Shah, Ph.D., M.B.A. CFO, Chief Accounting Officer
Jennifer J. Rhodes General Counsel
Allen R. Nissenson Board Member
Allen R. Nissenson, M.D. Board Member
Assaf Segal Board Member
Carol Ashe Board Member

Recent activity

Conference June 15th Conference Call Elicio Therapeutics, Inc. (ELTX)
2026-06-15